scholarly journals Propagated protein misfolding: New opportunities for therapeutics, new public health risk

2015 ◽  
Vol 41 (8) ◽  
pp. 196-199
Author(s):  
NR Cashman
2021 ◽  
pp. 1-19
Author(s):  
Lalit N. Patil

The key features of the electric vehicle (EV) from urban area emphasizes on clean air as well as quiet running nature to preserve atmospheric pollution conditions in the city, however, the new public health risk is arising due to calm running environment of electric vehicles. Since the electric vehicles run at low noise levels, pedestrians being troubled in road traffic accidents which tend to focus on the safety of the pedestrian. The aim of the present study is to analyze the perception of pedestrian’s and driver’s with the quiet nature of electric vehicles by evaluating the data obtained through a questionnaire survey and interviews conducted at the Mumbai Metropolitan Region (MMR), India. A total of 398 drivers of various driving experiences and 401 pedestrians from various locations of MMR had been responded to acquire technical data. A hypothesis is evaluated for public health risk associated with the quiet nature of electric vehicles from the driver’s gender and age perspective. In addition, the ANOVA study was carried out to test the statistical significance of risk with respect to age, gender, vehicle usage, driving experience. The results illustrate that moderate risk is associated with the quiet nature of EV and more attention is required by road users as well as drivers, nevertheless gender (P=0.3321), profession (P=0.6537), driving experience (P=0.8888), vehicle use (P=0.3819) are not significant based on driver’s perception (P value greater than 0.05), whereas driver age group (P=0.0000) is accountable for perceived risk. Similarly, considering pedestrian’s perception, gender (P=0.7954), profession (P=0.8188), distance walk (P=0.2313), location (P=0.3896) are not significant. The outcome of this study recommends the foremost need for the advanced control system in electric vehicles.


2020 ◽  
Vol 20 ◽  
Author(s):  
Miribane Dërmaku-Sopjani ◽  
Mentor Sopjani

Abstract:: The coronavirus disease 2019 (COVID-19) is currently a new public health crisis threatening the world. This pandemic disease is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus has been reported to be originated in bats and by yet unknown intermediary animals were transmitted to humans in China 2019. The SARSCoV- 2 spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERSCoV) but has reduced fatality. At present, the SARS-CoV-2 has caused about a 1.16 million of deaths with more than 43.4 million confirmed cases worldwide, resulting in a serious threat to public health globally with yet uncertain impact. The disease is transmitted by inhalation or direct contact with an infected person. The incubation period ranges from 1 to 14 days. COVID-19 is accompanied by various symptoms, including cough, fatigue. In most people the disease is mild, but in some other people, such as in elderly and people with chronic diseases, it may progress from pneumonia to a multi-organ dysfunction. Many people are reported asymptomatic. The virus genome is sequenced, but new variants are reported. Numerous biochemical aspects of its structure and function are revealed. To date, no clinically approved vaccines and/or specific therapeutic drugs are available to prevent or treat the COVID-19. However, there are reported intensive researches on the SARSCoV- 2 to potentially identify vaccines and/or drug targets, which may help to overcome the disease. In this review, we discuss recent advances in understanding the molecular structure of SARS-CoV-2 and its biochemical characteristics.


Sign in / Sign up

Export Citation Format

Share Document